Literature DB >> 16234632

Understanding diagnostic related groups (DRGs) and inpatient hospital reimbursement.

Laura Beaty1.   

Abstract

Knowing insurance plan regulations and complying precisely with requirements is critical for hospital reimbursement of care provided. Diagnostic related groups provide guidelines widely used in the United States to determine hospital reimbursement by Medicare, Medicaid, and many insurance providers. Because hospitals are the largest employers of nurses, nurses have a responsibility and interest in contributing to the stability of their hospital's financial status to protect incomes and job security. This article provides an overview of diagnostic related groups and demonstrates how nurses can contribute to more accurate documentation outcomes that determine hospital reimbursement.

Mesh:

Year:  2005        PMID: 16234632     DOI: 10.1097/00001610-200509000-00002

Source DB:  PubMed          Journal:  Gastroenterol Nurs        ISSN: 1042-895X            Impact factor:   0.978


  3 in total

1.  Costs Associated with Surgically Treated Cases of Abdominal Cystic Echinococcosis: A Single Center's Experience from 2008 to 2014, Pavia, Italy.

Authors:  Roberta Narra; Marcello Maestri; Christine M Budke; Francesca Tamarozzi; Mara Mariconti; Giovanni J Nicoletti; Francesca Rinaldi; Enrico Brunetti
Journal:  Am J Trop Med Hyg       Date:  2016-06-06       Impact factor: 2.345

2.  Effects of fee-for-service, diagnosis-related-group, and mixed payment systems on physicians' medical service behavior: experimental evidence.

Authors:  Xing Li; Yue Zhang; Xinyuan Zhang; Xinyan Li; Xing Lin; Youli Han
Journal:  BMC Health Serv Res       Date:  2022-07-05       Impact factor: 2.908

3.  Can Early Rehabilitation after Total Hip Arthroplasty Reduce Its Major Complications and Medical Expenses? Report from a Nationally Representative Cohort.

Authors:  Daniel Chiung-Jui Su; Kuo-Shu Yuan; Shih-Feng Weng; Rong-Bin Hong; Ming-Ping Wu; Hing-Man Wu; Willy Chou
Journal:  Biomed Res Int       Date:  2015-06-04       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.